Here are the 10-Q quarterly reports from Kaya Holdings Inc (KAYS) in our archive since June 2025, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 10-Q covers the quarterly report filed between annual reports, so if you follow KAYS and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full KAYS filings page.
Kaya Holdings (KAYS) reported very small assets and continuing heavy losses for the quarter and nine months ended September 30, 2025. Total assets were just $199,358, while total liabilities were $2,919,815, leaving a stockholders’ deficit of $2,720,457, improved from a deficit of $17.1 million at December 31, 2024 mainly due to large debt conversions to equity and derecognition of derivative liabilities.
For the nine months, net sales rose to $22,557 from $3,000 a year earlier, but the business remained far from scale. The company posted a net loss of $12,774,232 versus $3,243,797 in the prior-year period, driven largely by a $10,985,435 non-cash expense from changes in derivative liabilities and significant interest and discount amortization on convertible notes.
Cash was only $26,087, and the company used $459,666 in operating cash flows while raising $420,000 from new convertible notes. Management discloses a working capital deficiency of $2,422,383 and states that these conditions raise substantial doubt about its ability to continue as a going concern. The company has exited cannabis retail, sold its last OLCC license, and now focuses on psychedelic treatment operations through its Sacred Mushroom psilocybin service center.